Medication Tracking System Takes Aim at Counterfeit Drugs

January 28, 2014

A new medication tracking system is hoped to alleviate the gray market that thrives through diverting medications, as some hospitals and clinics (facing recent drug shortages) have turned to middle-men brokers. However, this increases the risk of counterfeit or unsafe drugs being administered to patients, FDA officials say. Counterfeit or altered medications can be diluted, inert or dangerous.

According to ONC Live, the tracking system was created under the auspices of the Drug Quality and Security Act from November 2013, and it was prompted by a trend of counterfeit prescription drug cases, including the 2012 deadly outbreak of fungal meningitis associated with tainted steroids.

The new system will:

Enable verification of the drug product identifier’s legitimacy down to the package level
Enhance detection and notification of illegitimate products in the drug supply chain
Facilitate more efficient drug products recalls

The development of the system will be phased in with new requirements over a 10-year period, the article reports.

Microsoft’s Edna Conway, Chief Security and Risk Officer of Azure, will lead this session and provide a real-world, tangible approach to address security and resilience to support you in your journey to operational resilience.

Protecting employees from potential exposure could be a daunting task, but with the right property technology, your office space can become an interactive and responsive asset that helps you ensure new health protocol compliance.